nodes	percent_of_prediction	percent_of_DWPC	metapath
Streptozocin—CYP2E1—Fingolimod—multiple sclerosis	0.221	0.291	CbGbCtD
Streptozocin—CYP2E1—Mitoxantrone—multiple sclerosis	0.104	0.137	CbGbCtD
Streptozocin—ABCB1—Methylprednisolone—multiple sclerosis	0.072	0.0949	CbGbCtD
Streptozocin—CYP1A1—Dexamethasone—multiple sclerosis	0.0698	0.0919	CbGbCtD
Streptozocin—CYP2E1—Dexamethasone—multiple sclerosis	0.0539	0.071	CbGbCtD
Streptozocin—ABCB1—Mitoxantrone—multiple sclerosis	0.0526	0.0692	CbGbCtD
Streptozocin—ABCB1—Betamethasone—multiple sclerosis	0.0468	0.0617	CbGbCtD
Streptozocin—ABCB1—Prednisolone—multiple sclerosis	0.0462	0.0609	CbGbCtD
Streptozocin—ABCB1—Prednisone—multiple sclerosis	0.0437	0.0575	CbGbCtD
Streptozocin—ABCB1—Dexamethasone—multiple sclerosis	0.0272	0.0359	CbGbCtD
Streptozocin—ABCB1—Methotrexate—multiple sclerosis	0.0219	0.0288	CbGbCtD
Streptozocin—Glucosamine—IFNG—multiple sclerosis	0.00572	0.486	CrCbGaD
Streptozocin—Myelosuppression—Cladribine—multiple sclerosis	0.00512	0.0302	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Prednisolone—multiple sclerosis	0.00481	0.0283	CcSEcCtD
Streptozocin—Hepatic enzyme increased—Fingolimod—multiple sclerosis	0.00448	0.0264	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Triamcinolone—multiple sclerosis	0.00442	0.0261	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Methylprednisolone—multiple sclerosis	0.00441	0.026	CcSEcCtD
Streptozocin—Myelosuppression—Azathioprine—multiple sclerosis	0.00416	0.0245	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Betamethasone—multiple sclerosis	0.00401	0.0237	CcSEcCtD
Streptozocin—Glucose tolerance impaired—Dexamethasone—multiple sclerosis	0.00401	0.0237	CcSEcCtD
Streptozocin—Febrile neutropenia—Cladribine—multiple sclerosis	0.00399	0.0235	CcSEcCtD
Streptozocin—Glucosamine—MMP9—multiple sclerosis	0.00364	0.31	CrCbGaD
Streptozocin—Glucose tolerance impaired—Prednisone—multiple sclerosis	0.00349	0.0206	CcSEcCtD
Streptozocin—Myelosuppression—Mitoxantrone—multiple sclerosis	0.00336	0.0198	CcSEcCtD
Streptozocin—Neoplasm malignant—Cladribine—multiple sclerosis	0.00281	0.0166	CcSEcCtD
Streptozocin—Extravasation—Cladribine—multiple sclerosis	0.00275	0.0162	CcSEcCtD
Streptozocin—Nephropathy toxic—Mitoxantrone—multiple sclerosis	0.00275	0.0162	CcSEcCtD
Streptozocin—SLC2A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00265	0.0445	CbGpPWpGaD
Streptozocin—Febrile neutropenia—Mitoxantrone—multiple sclerosis	0.00262	0.0155	CcSEcCtD
Streptozocin—Blood bilirubin increased—Cladribine—multiple sclerosis	0.00254	0.015	CcSEcCtD
Streptozocin—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00253	0.0149	CcSEcCtD
Streptozocin—Inflammation—Cladribine—multiple sclerosis	0.00247	0.0146	CcSEcCtD
Streptozocin—Glucosamine—TNF—multiple sclerosis	0.00239	0.204	CrCbGaD
Streptozocin—Neoplasm malignant—Azathioprine—multiple sclerosis	0.00229	0.0135	CcSEcCtD
Streptozocin—Anuria—Methotrexate—multiple sclerosis	0.00225	0.0133	CcSEcCtD
Streptozocin—Haematocrit decreased—Methotrexate—multiple sclerosis	0.00211	0.0124	CcSEcCtD
Streptozocin—Necrosis—Mitoxantrone—multiple sclerosis	0.00201	0.0119	CcSEcCtD
Streptozocin—SLC2A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00185	0.0311	CbGpPWpGaD
Streptozocin—Extravasation—Mitoxantrone—multiple sclerosis	0.00181	0.0107	CcSEcCtD
Streptozocin—Proteinuria—Mitoxantrone—multiple sclerosis	0.0018	0.0106	CcSEcCtD
Streptozocin—Lethargy—Cladribine—multiple sclerosis	0.00178	0.0105	CcSEcCtD
Streptozocin—Protein urine present—Mitoxantrone—multiple sclerosis	0.00177	0.0104	CcSEcCtD
Streptozocin—Hypocalcaemia—Mitoxantrone—multiple sclerosis	0.00172	0.0102	CcSEcCtD
Streptozocin—Blood bilirubin increased—Mitoxantrone—multiple sclerosis	0.00167	0.00984	CcSEcCtD
Streptozocin—Hepatic enzyme increased—Mitoxantrone—multiple sclerosis	0.00167	0.00984	CcSEcCtD
Streptozocin—Leukopenia—Fingolimod—multiple sclerosis	0.00166	0.00977	CcSEcCtD
Streptozocin—SLC2A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00159	0.0267	CbGpPWpGaD
Streptozocin—Febrile neutropenia—Prednisone—multiple sclerosis	0.00156	0.00922	CcSEcCtD
Streptozocin—SLC2A2—Developmental Biology—CD24—multiple sclerosis	0.00154	0.0258	CbGpPWpGaD
Streptozocin—Necrosis—Methylprednisolone—multiple sclerosis	0.00151	0.00893	CcSEcCtD
Streptozocin—Eosinophilia—Cladribine—multiple sclerosis	0.00149	0.00879	CcSEcCtD
Streptozocin—Blood urea increased—Mitoxantrone—multiple sclerosis	0.00149	0.00879	CcSEcCtD
Streptozocin—Azotaemia—Methotrexate—multiple sclerosis	0.00148	0.0087	CcSEcCtD
Streptozocin—Glycosuria—Triamcinolone—multiple sclerosis	0.00147	0.00867	CcSEcCtD
Streptozocin—Glycosuria—Methylprednisolone—multiple sclerosis	0.00147	0.00865	CcSEcCtD
Streptozocin—Pancytopenia—Cladribine—multiple sclerosis	0.00143	0.00844	CcSEcCtD
Streptozocin—Neutropenia—Cladribine—multiple sclerosis	0.00141	0.00831	CcSEcCtD
Streptozocin—Necrosis—Dexamethasone—multiple sclerosis	0.00138	0.00812	CcSEcCtD
Streptozocin—Necrosis—Betamethasone—multiple sclerosis	0.00138	0.00812	CcSEcCtD
Streptozocin—SLC2A2—Carbohydrate metabolism—GPC5—multiple sclerosis	0.00136	0.0228	CbGpPWpGaD
Streptozocin—SLC2A2—Type II diabetes mellitus—MAPK1—multiple sclerosis	0.00136	0.0228	CbGpPWpGaD
Streptozocin—Glycosuria—Dexamethasone—multiple sclerosis	0.00133	0.00786	CcSEcCtD
Streptozocin—Glycosuria—Betamethasone—multiple sclerosis	0.00133	0.00786	CcSEcCtD
Streptozocin—Febrile neutropenia—Methotrexate—multiple sclerosis	0.00131	0.00771	CcSEcCtD
Streptozocin—SLC2A2—Type II diabetes mellitus—TNF—multiple sclerosis	0.00129	0.0217	CbGpPWpGaD
Streptozocin—SLC2A2—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.00126	0.0211	CbGpPWpGaD
Streptozocin—Extravasation—Betamethasone—multiple sclerosis	0.00124	0.0073	CcSEcCtD
Streptozocin—Extravasation—Dexamethasone—multiple sclerosis	0.00124	0.0073	CcSEcCtD
Streptozocin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00124	0.0207	CbGpPWpGaD
Streptozocin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00124	0.0207	CbGpPWpGaD
Streptozocin—Inflammation—Methylprednisolone—multiple sclerosis	0.00122	0.00722	CcSEcCtD
Streptozocin—SLC2A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00121	0.0202	CbGpPWpGaD
Streptozocin—Necrosis—Prednisone—multiple sclerosis	0.0012	0.00707	CcSEcCtD
Streptozocin—Pancytopenia—Azathioprine—multiple sclerosis	0.00116	0.00686	CcSEcCtD
Streptozocin—Glycosuria—Prednisone—multiple sclerosis	0.00116	0.00685	CcSEcCtD
Streptozocin—Burning sensation—Methotrexate—multiple sclerosis	0.00113	0.00667	CcSEcCtD
Streptozocin—Erythema—Cladribine—multiple sclerosis	0.00105	0.00619	CcSEcCtD
Streptozocin—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.00104	0.00615	CcSEcCtD
Streptozocin—Diarrhoea—Fingolimod—multiple sclerosis	0.00103	0.0061	CcSEcCtD
Streptozocin—Hepatotoxicity—Methotrexate—multiple sclerosis	0.00102	0.006	CcSEcCtD
Streptozocin—Necrosis—Methotrexate—multiple sclerosis	0.001	0.00591	CcSEcCtD
Streptozocin—Anaemia—Cladribine—multiple sclerosis	0.00097	0.00572	CcSEcCtD
Streptozocin—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00094	0.00554	CcSEcCtD
Streptozocin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000931	0.0156	CbGpPWpGaD
Streptozocin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000931	0.0156	CbGpPWpGaD
Streptozocin—Neutropenia—Mitoxantrone—multiple sclerosis	0.000925	0.00546	CcSEcCtD
Streptozocin—Extravasation—Methotrexate—multiple sclerosis	0.000901	0.00531	CcSEcCtD
Streptozocin—Proteinuria—Methotrexate—multiple sclerosis	0.000895	0.00528	CcSEcCtD
Streptozocin—Protein urine present—Methotrexate—multiple sclerosis	0.000882	0.0052	CcSEcCtD
Streptozocin—Confusional state—Cladribine—multiple sclerosis	0.000863	0.00509	CcSEcCtD
Streptozocin—Oedema—Cladribine—multiple sclerosis	0.000856	0.00505	CcSEcCtD
Streptozocin—SLC2A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000843	0.0141	CbGpPWpGaD
Streptozocin—Thrombocytopenia—Cladribine—multiple sclerosis	0.000838	0.00495	CcSEcCtD
Streptozocin—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000831	0.0049	CcSEcCtD
Streptozocin—Inflammation—Methotrexate—multiple sclerosis	0.00081	0.00478	CcSEcCtD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000809	0.0136	CbGpPWpGaD
Streptozocin—Lethargy—Betamethasone—multiple sclerosis	0.0008	0.00472	CcSEcCtD
Streptozocin—Lethargy—Dexamethasone—multiple sclerosis	0.0008	0.00472	CcSEcCtD
Streptozocin—Anaemia—Azathioprine—multiple sclerosis	0.000788	0.00465	CcSEcCtD
Streptozocin—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000785	0.0132	CbGpPWpGaD
Streptozocin—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000785	0.0132	CbGpPWpGaD
Streptozocin—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000775	0.013	CbGpPWpGaD
Streptozocin—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000775	0.013	CbGpPWpGaD
Streptozocin—Leukopenia—Azathioprine—multiple sclerosis	0.000764	0.0045	CcSEcCtD
Streptozocin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000743	0.0125	CbGpPWpGaD
Streptozocin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000743	0.0125	CbGpPWpGaD
Streptozocin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00074	0.0124	CbGpPWpGaD
Streptozocin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00074	0.0124	CbGpPWpGaD
Streptozocin—Pain—Cladribine—multiple sclerosis	0.000732	0.00432	CcSEcCtD
Streptozocin—CYP1A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00073	0.0122	CbGpPWpGaD
Streptozocin—CYP1A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00073	0.0122	CbGpPWpGaD
Streptozocin—Hypokalaemia—Betamethasone—multiple sclerosis	0.000713	0.00421	CcSEcCtD
Streptozocin—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000713	0.00421	CcSEcCtD
Streptozocin—Feeling abnormal—Cladribine—multiple sclerosis	0.000706	0.00416	CcSEcCtD
Streptozocin—Lethargy—Prednisone—multiple sclerosis	0.000697	0.00411	CcSEcCtD
Streptozocin—Erythema—Mitoxantrone—multiple sclerosis	0.00069	0.00407	CcSEcCtD
Streptozocin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000682	0.00402	CcSEcCtD
Streptozocin—Body temperature increased—Cladribine—multiple sclerosis	0.000677	0.00399	CcSEcCtD
Streptozocin—Anaemia—Mitoxantrone—multiple sclerosis	0.000637	0.00376	CcSEcCtD
Streptozocin—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000636	0.0107	CbGpPWpGaD
Streptozocin—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000636	0.0107	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000634	0.0106	CbGpPWpGaD
Streptozocin—Hypokalaemia—Prednisone—multiple sclerosis	0.000621	0.00366	CcSEcCtD
Streptozocin—Leukopenia—Mitoxantrone—multiple sclerosis	0.000617	0.00364	CcSEcCtD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000613	0.0103	CbGpPWpGaD
Streptozocin—CYP1A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0006	0.0101	CbGpPWpGaD
Streptozocin—CYP1A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0006	0.0101	CbGpPWpGaD
Streptozocin—Diarrhoea—Cladribine—multiple sclerosis	0.000586	0.00346	CcSEcCtD
Streptozocin—Lethargy—Methotrexate—multiple sclerosis	0.000582	0.00343	CcSEcCtD
Streptozocin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000574	0.00338	CcSEcCtD
Streptozocin—Confusional state—Mitoxantrone—multiple sclerosis	0.000567	0.00335	CcSEcCtD
Streptozocin—Erythema—Prednisolone—multiple sclerosis	0.000566	0.00334	CcSEcCtD
Streptozocin—Oedema—Mitoxantrone—multiple sclerosis	0.000563	0.00332	CcSEcCtD
Streptozocin—Neutropenia—Prednisone—multiple sclerosis	0.000552	0.00325	CcSEcCtD
Streptozocin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000551	0.00325	CcSEcCtD
Streptozocin—Body temperature increased—Azathioprine—multiple sclerosis	0.00055	0.00325	CcSEcCtD
Streptozocin—Vomiting—Cladribine—multiple sclerosis	0.000544	0.00321	CcSEcCtD
Streptozocin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00053	0.00889	CbGpPWpGaD
Streptozocin—Erythema—Triamcinolone—multiple sclerosis	0.00052	0.00307	CcSEcCtD
Streptozocin—Erythema—Methylprednisolone—multiple sclerosis	0.000519	0.00306	CcSEcCtD
Streptozocin—Nausea—Cladribine—multiple sclerosis	0.000509	0.003	CcSEcCtD
Streptozocin—SLC2A2—Developmental Biology—PRNP—multiple sclerosis	0.000508	0.00853	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—SRM—multiple sclerosis	0.0005	0.00838	CbGpPWpGaD
Streptozocin—Eosinophilia—Methotrexate—multiple sclerosis	0.000488	0.00288	CcSEcCtD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000484	0.00812	CbGpPWpGaD
Streptozocin—Pain—Mitoxantrone—multiple sclerosis	0.000481	0.00284	CcSEcCtD
Streptozocin—Diarrhoea—Azathioprine—multiple sclerosis	0.000476	0.00281	CcSEcCtD
Streptozocin—Erythema—Dexamethasone—multiple sclerosis	0.000472	0.00278	CcSEcCtD
Streptozocin—Erythema—Betamethasone—multiple sclerosis	0.000472	0.00278	CcSEcCtD
Streptozocin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000472	0.00791	CbGpPWpGaD
Streptozocin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000472	0.00791	CbGpPWpGaD
Streptozocin—Pancytopenia—Methotrexate—multiple sclerosis	0.000468	0.00276	CcSEcCtD
Streptozocin—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000466	0.00781	CbGpPWpGaD
Streptozocin—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000466	0.00781	CbGpPWpGaD
Streptozocin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000464	0.00274	CcSEcCtD
Streptozocin—Oedema—Prednisolone—multiple sclerosis	0.000462	0.00272	CcSEcCtD
Streptozocin—Neutropenia—Methotrexate—multiple sclerosis	0.000461	0.00272	CcSEcCtD
Streptozocin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000445	0.00262	CcSEcCtD
Streptozocin—Vomiting—Azathioprine—multiple sclerosis	0.000443	0.00261	CcSEcCtD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000428	0.00718	CbGpPWpGaD
Streptozocin—Confusional state—Methylprednisolone—multiple sclerosis	0.000427	0.00252	CcSEcCtD
Streptozocin—Oedema—Triamcinolone—multiple sclerosis	0.000425	0.0025	CcSEcCtD
Streptozocin—Nausea—Azathioprine—multiple sclerosis	0.000414	0.00244	CcSEcCtD
Streptozocin—Erythema—Prednisone—multiple sclerosis	0.000411	0.00243	CcSEcCtD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000405	0.00678	CbGpPWpGaD
Streptozocin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000405	0.00678	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000403	0.00676	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000398	0.00668	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—PTPRC—multiple sclerosis	0.000395	0.00663	CbGpPWpGaD
Streptozocin—Pain—Prednisolone—multiple sclerosis	0.000395	0.00233	CcSEcCtD
Streptozocin—Oedema—Dexamethasone—multiple sclerosis	0.000385	0.00227	CcSEcCtD
Streptozocin—Oedema—Betamethasone—multiple sclerosis	0.000385	0.00227	CcSEcCtD
Streptozocin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000385	0.00227	CcSEcCtD
Streptozocin—SLC2A2—Disease—GPC5—multiple sclerosis	0.000385	0.00645	CbGpPWpGaD
Streptozocin—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000383	0.00641	CbGpPWpGaD
Streptozocin—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000383	0.00641	CbGpPWpGaD
Streptozocin—Feeling abnormal—Prednisolone—multiple sclerosis	0.00038	0.00224	CcSEcCtD
Streptozocin—Anaemia—Prednisone—multiple sclerosis	0.00038	0.00224	CcSEcCtD
Streptozocin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000377	0.00223	CcSEcCtD
Streptozocin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000377	0.00223	CcSEcCtD
Streptozocin—Pain—Triamcinolone—multiple sclerosis	0.000363	0.00214	CcSEcCtD
Streptozocin—Vomiting—Mitoxantrone—multiple sclerosis	0.000358	0.00211	CcSEcCtD
Streptozocin—SLC2A2—Metabolism—CYP24A1—multiple sclerosis	0.000352	0.0059	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—CYP27B1—multiple sclerosis	0.000352	0.0059	CbGpPWpGaD
Streptozocin—CYP1A1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000352	0.0059	CbGpPWpGaD
Streptozocin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00035	0.00206	CcSEcCtD
Streptozocin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000349	0.00206	CcSEcCtD
Streptozocin—CYP1A1—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000347	0.00581	CbGpPWpGaD
Streptozocin—Erythema—Methotrexate—multiple sclerosis	0.000344	0.00203	CcSEcCtD
Streptozocin—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000338	0.00567	CbGpPWpGaD
Streptozocin—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000338	0.00567	CbGpPWpGaD
Streptozocin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000336	0.00198	CcSEcCtD
Streptozocin—Oedema—Prednisone—multiple sclerosis	0.000336	0.00198	CcSEcCtD
Streptozocin—Nausea—Mitoxantrone—multiple sclerosis	0.000334	0.00197	CcSEcCtD
Streptozocin—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000333	0.00559	CbGpPWpGaD
Streptozocin—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000333	0.00559	CbGpPWpGaD
Streptozocin—Pain—Betamethasone—multiple sclerosis	0.000329	0.00194	CcSEcCtD
Streptozocin—Pain—Dexamethasone—multiple sclerosis	0.000329	0.00194	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000329	0.00551	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000329	0.00551	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—GPC5—multiple sclerosis	0.000322	0.0054	CbGpPWpGaD
Streptozocin—CYP1A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000319	0.00534	CbGpPWpGaD
Streptozocin—CYP1A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000319	0.00534	CbGpPWpGaD
Streptozocin—Anaemia—Methotrexate—multiple sclerosis	0.000318	0.00187	CcSEcCtD
Streptozocin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000317	0.00187	CcSEcCtD
Streptozocin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000317	0.00187	CcSEcCtD
Streptozocin—CYP1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000314	0.00527	CbGpPWpGaD
Streptozocin—CYP1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000314	0.00527	CbGpPWpGaD
Streptozocin—Leukopenia—Methotrexate—multiple sclerosis	0.000308	0.00181	CcSEcCtD
Streptozocin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000305	0.00511	CbGpPWpGaD
Streptozocin—Body temperature increased—Betamethasone—multiple sclerosis	0.000305	0.0018	CcSEcCtD
Streptozocin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000305	0.0018	CcSEcCtD
Streptozocin—SLC2A2—NRF2 pathway—TGFB1—multiple sclerosis	0.000305	0.00511	CbGpPWpGaD
Streptozocin—SLC2A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000303	0.00509	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000299	0.00502	CbGpPWpGaD
Streptozocin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00029	0.00171	CcSEcCtD
Streptozocin—Confusional state—Methotrexate—multiple sclerosis	0.000283	0.00167	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000282	0.00473	CbGpPWpGaD
Streptozocin—Feeling abnormal—Prednisone—multiple sclerosis	0.000276	0.00163	CcSEcCtD
Streptozocin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000275	0.00162	CcSEcCtD
Streptozocin—Nausea—Prednisolone—multiple sclerosis	0.000274	0.00162	CcSEcCtD
Streptozocin—Vomiting—Triamcinolone—multiple sclerosis	0.00027	0.00159	CcSEcCtD
Streptozocin—Vomiting—Methylprednisolone—multiple sclerosis	0.000269	0.00159	CcSEcCtD
Streptozocin—SLC2A2—Metabolism—RRM1—multiple sclerosis	0.000267	0.00447	CbGpPWpGaD
Streptozocin—Body temperature increased—Prednisone—multiple sclerosis	0.000265	0.00156	CcSEcCtD
Streptozocin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000264	0.00156	CcSEcCtD
Streptozocin—Diarrhoea—Betamethasone—multiple sclerosis	0.000264	0.00156	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000256	0.00429	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000254	0.00426	CbGpPWpGaD
Streptozocin—Nausea—Triamcinolone—multiple sclerosis	0.000252	0.00149	CcSEcCtD
Streptozocin—Nausea—Methylprednisolone—multiple sclerosis	0.000252	0.00148	CcSEcCtD
Streptozocin—SLC2A2—Disease—RPL5—multiple sclerosis	0.00025	0.00419	CbGpPWpGaD
Streptozocin—Vomiting—Betamethasone—multiple sclerosis	0.000245	0.00145	CcSEcCtD
Streptozocin—Vomiting—Dexamethasone—multiple sclerosis	0.000245	0.00145	CcSEcCtD
Streptozocin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000243	0.00408	CbGpPWpGaD
Streptozocin—Pain—Methotrexate—multiple sclerosis	0.00024	0.00141	CcSEcCtD
Streptozocin—SLC2A2—Disease—SLC11A1—multiple sclerosis	0.00024	0.00402	CbGpPWpGaD
Streptozocin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000231	0.00136	CcSEcCtD
Streptozocin—Diarrhoea—Prednisone—multiple sclerosis	0.00023	0.00135	CcSEcCtD
Streptozocin—Nausea—Betamethasone—multiple sclerosis	0.000229	0.00135	CcSEcCtD
Streptozocin—Nausea—Dexamethasone—multiple sclerosis	0.000229	0.00135	CcSEcCtD
Streptozocin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000224	0.00376	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000222	0.00372	CbGpPWpGaD
Streptozocin—Body temperature increased—Methotrexate—multiple sclerosis	0.000222	0.00131	CcSEcCtD
Streptozocin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000221	0.00371	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000216	0.00362	CbGpPWpGaD
Streptozocin—Vomiting—Prednisone—multiple sclerosis	0.000213	0.00126	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000206	0.00346	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000205	0.00343	CbGpPWpGaD
Streptozocin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000203	0.00341	CbGpPWpGaD
Streptozocin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000203	0.00341	CbGpPWpGaD
Streptozocin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0002	0.00336	CbGpPWpGaD
Streptozocin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0002	0.00336	CbGpPWpGaD
Streptozocin—Nausea—Prednisone—multiple sclerosis	0.000199	0.00118	CcSEcCtD
Streptozocin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000197	0.0033	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000194	0.00325	CbGpPWpGaD
Streptozocin—Diarrhoea—Methotrexate—multiple sclerosis	0.000192	0.00113	CcSEcCtD
Streptozocin—SLC2A2—Disease—CD28—multiple sclerosis	0.000191	0.00321	CbGpPWpGaD
Streptozocin—Vomiting—Methotrexate—multiple sclerosis	0.000178	0.00105	CcSEcCtD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000177	0.00297	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—TYK2—multiple sclerosis	0.000177	0.00297	CbGpPWpGaD
Streptozocin—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000177	0.00296	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000171	0.00287	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000171	0.00287	CbGpPWpGaD
Streptozocin—Nausea—Methotrexate—multiple sclerosis	0.000167	0.000983	CcSEcCtD
Streptozocin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000166	0.00279	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.00016	0.00268	CbGpPWpGaD
Streptozocin—SLC2A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000154	0.00259	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000154	0.00258	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—BCHE—multiple sclerosis	0.000153	0.00257	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000153	0.00256	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000152	0.00255	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000151	0.00253	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000151	0.00253	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000147	0.00246	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000144	0.00241	CbGpPWpGaD
Streptozocin—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000143	0.0024	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—MMP9—multiple sclerosis	0.000139	0.00234	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—CD86—multiple sclerosis	0.000136	0.00229	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000135	0.00227	CbGpPWpGaD
Streptozocin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000135	0.00226	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000135	0.00226	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000133	0.00223	CbGpPWpGaD
Streptozocin—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.00013	0.00219	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—STAT3—multiple sclerosis	0.000124	0.00208	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000122	0.00205	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000122	0.00205	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000122	0.00204	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—CCR5—multiple sclerosis	0.000121	0.00203	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000119	0.002	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000119	0.00199	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—HLA-A—multiple sclerosis	0.000118	0.00198	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000116	0.00195	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—TGFB1—multiple sclerosis	0.000115	0.00193	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—MAPK1—multiple sclerosis	0.000113	0.00189	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000112	0.00188	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000111	0.00186	CbGpPWpGaD
Streptozocin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000111	0.00186	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—APOE—multiple sclerosis	0.00011	0.00185	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000109	0.00183	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—TNF—multiple sclerosis	0.000107	0.0018	CbGpPWpGaD
Streptozocin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00178	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.0001	0.00168	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—CD80—multiple sclerosis	9.95e-05	0.00167	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	9.74e-05	0.00163	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	9.72e-05	0.00163	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	9.71e-05	0.00163	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—APOE—multiple sclerosis	9.22e-05	0.00155	CbGpPWpGaD
Streptozocin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	9.04e-05	0.00152	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	8.88e-05	0.00149	CbGpPWpGaD
Streptozocin—SLC2A2—Developmental Biology—IL6—multiple sclerosis	8.65e-05	0.00145	CbGpPWpGaD
Streptozocin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.61e-05	0.00144	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—TYK2—multiple sclerosis	8.4e-05	0.00141	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—SRM—multiple sclerosis	8.2e-05	0.00138	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—POMC—multiple sclerosis	7.92e-05	0.00133	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.92e-05	0.00133	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.89e-05	0.00132	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.8e-05	0.00131	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.8e-05	0.00131	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.8e-05	0.00131	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—SRM—multiple sclerosis	7.74e-05	0.0013	CbGpPWpGaD
Streptozocin—CYP2E1—Biological oxidations—POMC—multiple sclerosis	7.6e-05	0.00127	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—CD4—multiple sclerosis	7.6e-05	0.00127	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.59e-05	0.00127	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.58e-05	0.00127	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	7.57e-05	0.00127	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.42e-05	0.00124	CbGpPWpGaD
Streptozocin—SLC2A2—Metabolism—ALB—multiple sclerosis	7.22e-05	0.00121	CbGpPWpGaD
Streptozocin—CYP1A1—Biological oxidations—POMC—multiple sclerosis	7.17e-05	0.0012	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	7.07e-05	0.00119	CbGpPWpGaD
Streptozocin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.07e-05	0.00119	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.68e-05	0.00112	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—SRM—multiple sclerosis	6.18e-05	0.00104	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	6.15e-05	0.00103	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.99e-05	0.001	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—STAT3—multiple sclerosis	5.88e-05	0.000987	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	5.78e-05	0.000969	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	5.78e-05	0.000969	CbGpPWpGaD
Streptozocin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.75e-05	0.000963	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—MYC—multiple sclerosis	5.47e-05	0.000917	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—TGFB1—multiple sclerosis	5.45e-05	0.000915	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	5.45e-05	0.000914	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	5.45e-05	0.000914	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—MAPK1—multiple sclerosis	5.35e-05	0.000897	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.33e-05	0.000893	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.29e-05	0.000888	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—GPC5—multiple sclerosis	5.29e-05	0.000887	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—GPC5—multiple sclerosis	4.98e-05	0.000836	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—SRM—multiple sclerosis	4.93e-05	0.000827	CbGpPWpGaD
Streptozocin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.57e-05	0.000766	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—RRM1—multiple sclerosis	4.38e-05	0.000735	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.35e-05	0.00073	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.35e-05	0.00073	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—RRM1—multiple sclerosis	4.13e-05	0.000693	CbGpPWpGaD
Streptozocin—SLC2A2—Disease—IL6—multiple sclerosis	4.11e-05	0.000689	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—GPC5—multiple sclerosis	3.98e-05	0.000668	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.47e-05	0.000583	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.47e-05	0.000583	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.4e-05	0.00057	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—RRM1—multiple sclerosis	3.3e-05	0.000553	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.2e-05	0.000537	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.18e-05	0.000533	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.04e-05	0.00051	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.04e-05	0.000509	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.98e-05	0.000499	CbGpPWpGaD
Streptozocin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.84e-05	0.000475	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.75e-05	0.000462	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.63e-05	0.000442	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.52e-05	0.000422	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.51e-05	0.000421	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—BCHE—multiple sclerosis	2.37e-05	0.000398	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.04e-05	0.000343	CbGpPWpGaD
Streptozocin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.91e-05	0.00032	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.89e-05	0.000318	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.76e-05	0.000294	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.6e-05	0.000268	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—APOE—multiple sclerosis	1.51e-05	0.000254	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000254	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—APOE—multiple sclerosis	1.43e-05	0.000239	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000218	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—POMC—multiple sclerosis	1.23e-05	0.000206	CbGpPWpGaD
Streptozocin—CYP2E1—Metabolism—ALB—multiple sclerosis	1.19e-05	0.000199	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000191	CbGpPWpGaD
Streptozocin—CYP1A1—Metabolism—ALB—multiple sclerosis	1.12e-05	0.000187	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—POMC—multiple sclerosis	9.79e-06	0.000164	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—APOE—multiple sclerosis	9.1e-06	0.000153	CbGpPWpGaD
Streptozocin—ABCB1—Metabolism—ALB—multiple sclerosis	8.93e-06	0.00015	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—POMC—multiple sclerosis	7.82e-06	0.000131	CbGpPWpGaD
Streptozocin—CYP1A2—Metabolism—ALB—multiple sclerosis	7.13e-06	0.00012	CbGpPWpGaD
